ODDB.org: Open Drug Database

Swissmedic Registration	63166	Date of registration	12.09.2014
Company name	Roche Pharma (Schweiz) AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.15.	Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Actemra 162 mg/0.9 ml	Injektionslösung zur subkutanen Anwendung	Injektionslösung zur subkutanen Anwendung (Tocilizumabum 162mg / 0.9ml)	L04AC07	CI

2025	©ywesee GmbH